Clinical Trial Update: Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cyproheptadine to prevent weight loss in children undergoing cancer chemotherapy was terminated, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Cyproheptadine (cyproheptadine)

Snippet

Sponsor: University of South Florida | Conditions: Cancer | Phase 3 | Status: TERMINATED | Results posted: 2015-07-02